Importantly, ZLD2218 blocked UUO-induced activation of the TGF-β/Smad3 signaling pathway and suppressed α-SMA, COL I, COL IV and FN expression, significantly attenuating renal fibrosis and renal injury [258]. The gene discussed is ACTA1; the disease is renal fibrosis.